Objectives: Treatment of critical-sized bone defects with cells and biomaterials offers an efficient alternative to traditional bone grafts. Chitosan (CS) is a natural biopolymer that acts as a scaffold in bone tissue engineering (BTE). Polyphosphate (PolyP), recently identified as an inorganic polymer, acts as a potential bone morphogenetic material, whereas pigeonite (Pg) is a novel iron-containing ceramic. In this study, we prepared and characterized scaffolds containing CS, calcium polyphosphate (CaPP) and Pg particles for bone formation in vitro and in vivo. 
| INTRODUCTION
Defects in the skeletal system hamper normal bone functions. Recent statistical surveys have substantially evidenced the increased prevalence of such critical-sized bone defects around the world. 1 Owing to the innumerable constraints associated with conventional grafting techniques and the increasing rates of non-self-healing bone defects, bone tissue engineering (BTE) indisputably continues to gain clinical significance. Development of temporary matrices known as scaffolds is one of the key processes of the tissue engineering approach for reconstruction of the defective bone. Therefore, strenuous efforts are being made by researchers to design an ideal guiding matrix to restore bone defects.
Chitosan (CS) is a natural, semi-crystalline, cationic polysaccharide with biocompatibility and structure similar to that of glycosaminoglycans. It also exhibits antibacterial properties and is biodegradable.
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Polyphosphate (PolyP) was recently identified as a naturally occurring, morphogenetically active, inorganic polymer composed of linearly arranged phosphate units linked together by high-energy phosphoanhydride bonds. Chemically or enzymatically prepared PolyP has emerged as potential bone morphogenetic material for the treatment of human bone disorders like osteoporosis. 5 Several studies have identified the presence of PolyP-hydrolysing enzymes in osteoblast-like cells.
The action of exopolyphosphatases and endopolyphosphatases of the body facilitates breakdown of PolyP units to orthophosphates, which are similar to inorganic phosphates in inducing mineralization in bone cells, whereby PolyP can replace β-glycerophosphate (β-GP), a conventionally used ingredient of the osteogenic activation cocktail. 6 PolyP (Ca 2+ complex) in a stoichiometric ratio has been shown to promote hydroxyapatite (HAp) mineralization to a considerably higher extent than β-GP and could also inhibit osteoclasts. 7, 8 Iron plays an important role in maintaining bone physiology by serving as a cofactor for collagen synthesis and by improving bone mineral density (BMD).
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Iron oxide (FeO)-reinforced polycaprolactone (PCL) nanofibers, FeO/ Collagen/HAp and PCL/magnetic nanoparticles (MNPs/FeO NPs)
have been explored in recent years as iron-based biocomposites for bone tissue regeneration. [11] [12] [13] [14] Nanophase ceramics have gained increasing attention because of their superior bioactivity as well as structural and compositional similarity to bone extracellular matrix.
The biological role of ceramics like nBGCs, nHAp, diopside (Dp), mesoporous wollastonite (m-Ws) in BTE has been reported. [15] [16] [17] [18] Pigeonite (Pg), containing repeating units of (Ca,Mg,Fe)(Mg,Fe)Si 2 O 6 , is a novel iron-containing nanophase ceramic, and its role in bone regeneration
has not yet been determined. Hence, in this study, we developed CSbased scaffolds containing calcium polyphosphate (CaPP) and Pg particles and tested their potential towards promoting bone formation in vitro and in vivo.
| MATERIALS AND METHODS

| Preparation and characterization of CS/CaPP and CS/CaPP/Pg scaffolds
Pg particles were prepared by the co-precipitation method, 19 as shown in Table S1 , and the particle size was reduced by the wet-ball milling process ( Figure S1 ). CaPP was prepared as described previously. 20 Briefly, 5% CS solution in acetic acid was mixed with 5% CaPP solution in a ratio of 4:1 v/v. Pg particles at concentrations 0.25%-1% were dispersed into the existing solution and stirred for 1 hour to ensure homogeneous dispersion. The solution was transferred to 24-well culture plates, frozen at −20°C overnight and lyophilized.
The scaffolds were cross-linked in 2% alginate dialdehyde (ADA), as reported earlier. 21 The pH was neutralized using 0.1 mol/L NaOH and the scaffolds were lyophilized. The prepared CS/CaPP and CS/ CaPP/Pg scaffolds were subjected to SEM, XRD and EDAX studies, as described previously.
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| Preparation of conditioned media and assessment of ionic dissolution by ICP-OES
Freeze-dried CS/CaPP and CS/CaPP/Pg scaffolds (0.5 g) were incubated for 24 hours in the culture media at 37°C. The dissoluted products from the media were collected, syringe-filtered using a 0.2 μm syringe filter and used for further experiments. The supernatant was then analysed using an inductively coupled plasma optical emission spectrometer (ICP-OES; PerkinElmer, Optima 5300 DV, Shelton, USA)
to measure the levels of calcium (Ca), silicon (Si), phosphorus (P), magnesium (Mg) and iron (Fe) released from the scaffolds.
| Biocompatibility assessment
Cytotoxicity of scaffolds was determined by the MTT assay.
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Fluorescein diacetate (FDA) and Hoechst 33 342 were used as the cytoskeletal and nuclear stains, respectively. The dyes were added to cover the cell monolayers and the cells were incubated for 30 minutes at 37°C in the dark. 22, 23 The excess stain was removed, and the cells marker genes. In vivo implantation of scaffolds in rat critical-sized tibial defects displayed accelerated bone formation after 8 weeks.
Conclusion:
The current findings indicate that CS/CaPP scaffolds containing ironcontaining Pg particles serve as an appropriate template to support proliferation and differentiation of MSCs to osteoblasts in vitro and bone formation in vivo and thus support their candidature for BTE applications.
were washed with PBS and observed under a fluorescent microscope under the 40× objective lens.
| Cell viability, cell count and cell cycle phase analyses
Mouse mesenchymal stem cells (mMSCs; C3H10T1/2) were seeded in 12-well plates and serum starved for 6 hours in Dulbecco Modified
Eagle Medium (DMEM) containing 0.1% FBS to obtain a synchronous population. These cells were incubated in medium (25 mg/ mL) conditioned with scaffolds (CS/CaPP, CS/CaPP/0.25%Pg) as described previously. 24 Cells without treatment served as control. After incubation, cells were harvested and subjected to cell count and viability assays by using MUSE™ Cell Analyzer (Merck-Millipore, Germany) according to the manufacturer's protocol. The trypsinized cells were subjected to cell cycle phase analysis, as described previously. 
| Alizarin red staining and ALP staining
Mouse mesenchymal stem cells were cultured in the absence or presence of conditioned media in DMEM with 10% FBS for 7 days.
The medium was changed once in 2 days. The cultured cells were then subjected to Alizarin red (AR) and ALP staining, as described previously.
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| Real-time RT-PCR and western blot analyses
Total RNA was isolated from mMSCs, using TRIzol. cDNA synthesis and real-time PCR were performed as described previously. 26 The primers used in the study are shown in Table 1 . The relative mRNA expression was calculated using the ΔΔCt method. 27 Whole cell lysates were prepared from mMSCs, and the proteins were subjected to western blot analysis as described previously. 27 The proteins of interest were detected using an enhanced chemiluminescence detection kit (WESTAR SUPERNOVA, Cyanagen, Bologna, Italia) and quantified using Image Lab version 4.1 (BioRad, Hercules, CA, USA) software.
α-Tubulin was used for normalization. Laboratory Animals. Prior to surgery, the rats were anaesthetized with 5% isoflurane and subjected to perforation of the right tibia, using a dental drill with 3 mm diameter, under constant saline irrigation (0.9% NaCl), as described previously. 18 
| Histological processing
The implanted bone/scaffold implants were collected from animals and subjected to haematoxylin and eosin (H&E) staining and Masson's trichrome staining (MTS) individually, as described previously.
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| SEM and EDAX analyses
The calcified and unstained sections of the bone were analysed by SEM-EDAX for identifying the extent of mineralization at the implant- 
| Statistical analysis
All experiments were performed in triplicates, and the results were expressed as the mean ± standard deviation (SD). Statistical significance T A B L E 1 Primer sequences used for real-time reverse transcriptase PCR analysis was calculated by ANOVA and Student's t test. A P value lower than .05 was considered significant.
| RESULTS
| Physical characterization of scaffolds and their cytocompatibility assessment
The synthesized Pg particles depicted a mean size of about 400 nm,
as assessed by SEM ( Figure S1A ) and Dynamic Light Scattering (DLS) Figure 2D ). The presence of Ca and P/HAp was also confirmed by EDS analysis ( Figure 2E ).
Before the in vitro testing of any implantable biomaterial, it is crucial to evaluate the biocompatibility of the biomaterial in terms of the non-toxic concentration. As CS/CaPP scaffolds containing 0.25% and 0.5%Pg particles showed enhanced bioactivity (protein adsorption and biomineralization), the cytotoxicity of these scaffolds was assessed by the MTT assay. CS/CaPP/0.25%Pg scaffolds at the concentrations from 1 μg/mL to 25 mg/mL showed increased cell viability in mMSCs after 24 hours (Figure 3 ). Fluorescent staining of cells with FDA ( Figure   S2A ) and Hoechst 33342 ( Figure S2B ) showed no change in their morphology when they were grown in conditioned media obtained from the scaffolds. Light microscopic and FDA staining of mMSCs directly grown on scaffolds also showed no change in their morphology ( Figure S2C,D) . Despite the potential bioactive nature of ceramics, it is generally anticipated that the release of the constituent ions is expected to be well within the physiological levels to avoid discernible cytotoxic effects. Hence, the levels of the constituent ions, namely
Ca, Mg, Si, Fe and P, released from the scaffolds were assessed at F I G U R E 3 In vitro cytotoxicity of mouse mesenchymal stem cells (mMSCs; C3H10T1/2). mMSCs at 4 × 10 4 cells/cm 2 were treated with 1 μg/mL to 25 mg/mL of conditioned media obtained from CS/CaPP, CS/CaPP/0.25%Pg and CS/CaPP/0.5%Pg scaffolds for 24 h followed by MTT assay. Cells treated with Triton X-100 and culture medium served as positive and negative controls, respectively. *A significant increase compared to control (P < .05) particles showed lesser ionic dissolutions of Ca and P than CS/CaPP at 24 hours and 72 hours. This could be attributed to the previously observed reduction in the degradation ability of CS/CaPP/Pg (Figure 2A) because of a strong physical interaction due to the addition of ceramics. Release of Mg, Fe and Si from Pg particles was found to be within the physiological permissible levels. Notably, Ca, Si and P ions released from the scaffold have previously been reported to exert a stimulatory response to cell proliferation and differentiation.
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| CS/CaPP/0.25%Pg scaffolds enhanced cell proliferation
As CS/CaPP/0.25%Pg scaffolds showed increased cell viability (Figure 3 ), we next determined their effect on cell proliferation. showed increased collagen in the defective areas filled with scaffolds compared with the control ( Figure 7G ).
| DISCUSSION
Biomaterials incorporated with growth factors (GFs) have been widely used as guiding matrices in BTE to promote bone formation. However, their shorter half-life, decreased bioavailability and high cost limit their application. 33 Efforts to establish alternative yet equivalently effective approaches to GF delivery for BTE led to the investigation of naturally F I G U R E 5 Effect of scaffolds on the expression of cyclin genes in mouse mesenchymal stem cells (mMSCs). Cells were treated with CS/CaPP and CS/CaPP/Pg scaffolds for 24 h in medium containing 10% serum. Untreated cells grown in media containing 10% serum served as control. A, Total RNA was isolated and subjected to realtime RT PCR using the primers for cyclin genes. RPL13B was used as internal control. The relative mRNA expression of cyclins was determined after normalization with RPL13B gene. *A significant increase compared with the control (P < .05). #Significant increase compared with CS/CaPP scaffolds (P < .05). B, Whole cell lysates were prepared and subjected to western blot analysis using the antibodies as indicated. α-Tubulin was used as internal control. The relative expression of cyclins was determined after normalization with α-tubulin by using Image J software. Results of western blotting analysis of cyclin(s) A, B and C proteins in response to scaffold treatment at 24 h are shown. mMSCs were treated with CS/CaPP and CS/CaPP/Pg scaffolds for 24 h in medium containing 10% serum. Untreated cells grown in media containing 10% serum served as control. The whole cell lysates were prepared and western blotting was performed for the antibodies of cyclins A, B and C. α-Tubulin was used as the internal loading control. C, D, E Relative expression of cyclin(s) normalized to α-tubulin by using Image J software
occurring bone morphogenetic substances like Bio-silica and PolyP. 6, [34] [35] [36] PolyP-mediated modulation of osteoblast-specific gene expression has been studied in MC3T3E1, SaOS2 and MSCs. 20, 34, 37, 38 To the best of our knowledge, there were no reports available to support the role of Pg and its composite scaffolds in bone formation. In this study, we developed CS-based scaffolds and tested the components, CaPP and Pg particles, for their ability to promote bone formation in vitro and in vivo.
CS/CaPP/0.25%Pg scaffolds were found to have bioactivity by protein adsorption and biomineralization ( Figure 2B,D) . Protein adsorption of scaffolds plays a key role for cell attachment and proliferation. 17, 22, 39 The formation of silanol (Si-OH) groups in silica-rich ceramics upon interaction with SBF contributes to its superior bioactivity. Additionally, the larger surface area attributed to nanophase materials would have facilitated increased CaPP crystal nucleation and growth, thereby promoting biomineralization. However, when the concentration of Pg increased beyond 0.5%, there was decrease in the deposits, which could be due to loss of nanophase by the possible aggregation of particles.
Compared to the CS/CaPP scaffolds, CS/CaPP/0.25%Pg scaffolds showed increased compressive strength and modulus ( Figure 2C ). This increased mechanical property facilitates reduced degradation of the scaffolds under physiological conditions. These scaffolds were found to be non-toxic to mMSCs (Figure 3) , and the cells under fluorescent microscopy showed no visible alteration in their cytoskeletal morphology or distortion in the intact structure of the nucleus ( Figure S2A ,B).
Cell cycle phase transition from G0/G1 to G2/M phases mediated by the treatment with the CS/CaPP/0.25%Pg scaffolds in mMSCs F I G U R E 6 Effect of scaffolds on osteoblast differentiation at the cellular and molecular levels. Mouse mesenchymal stem cells (mMSCs) were treated with conditioned media obtained from Chitosan (CS)/CaPP and CS/CaPP/Pg scaffolds for 14 days. They were subjected to Alizarin red (AR) and alkaline phosphatase (ALP) staining. A and B, The representative light microscopic image and the quantified areas of the AR staining, respectively. C and D, The representative light microscopic image and the quantified areas of the ALP staining, respectively. *A significant increase compared with the control (P < .05). #A significant increase compared with CS/CaPP scaffolds (P < .05). E, F, G and H, The relative mRNA expression of Runx2, ALP, type I Col-1 and OC, respectively. *A significant increase compared with the control (P < .05). #A significant increase compared with CS/CaPP scaffolds (P < .05) bioceramic particles resulted in release of ions such as Ca, Mg, Si and P, which were internalized by cells and led to activation of intracellular signalling cascades, resulting in enhancement of cellular processes like cell proliferation, differentiation, mineralization and vascularization. 40 The increased metabolic activity of cells could have positively influenced the proliferation of cells. [31] [32] [33] We previously showed that ceramics like nBGC, diopside and wollastonite have similar positive effects in promoting cell attachment and proliferation. [15] [16] [17] [18] Further, the biological effects of these ceramics were enhanced when composited with CS-based natural polymers. 17, 22, [41] [42] [43] [44] PolyP-based inorganic polymers showed increased cell proliferation, which was found to be due to the stimulation of bFGF and increased intracellular accumulation of calcium and ATP. Runx2 is a key transcription factor required for the differentia- In conclusion, this study evidenced the plausible roles of a novel iron-containing ceramic, pigeonite, and bone morphogenetic substance, CaPP, in CS-based composite scaffolds for bone formation. The scaffolds containing Pg particles showed enhanced effect on both proliferation and osteoblast differentiation of mMSCs in vitro.
The study also demonstrated the in vivo bone-forming potential of the scaffolds in rat critical-sized tibial defect. Thus, the observations of our current study conclusively support the suitability of CS/CaPP/Pg composite scaffolds in the field of stem cells and BTE, and suggest that these scaffolds could further be established as suitable candidates to be employed as stem cell-based composites, as bone substitutes for orthopaedic repair.
